Compounded Pharmacy Market: Personalized Medicine Drives Growth at 7% CAGR

Market Overview

Compounded Pharmacy Market Research Report Information By Product (Topical Medications, Parenteral Medications, Oral Medications, and Other Medications), By Therapeutic Area (Hormone Replacement, Pain Management, Dermal Disorders, and Others), By Compounding Type (Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing, Pharmaceutical Dosage Alteration, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

Compounded Pharmacy Market Size was valued at USD 15.2 Billion in 2023. The compounded pharmacy market industry is projected to grow from USD 16.6 Billion in 2024 to USD 26.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.00% during the forecast period (2024 – 2032).

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/22115

Market Dynamics

The trend towards personalized medicine is driving the growth of the compounded pharmacy market. Personalized medicine aims to tailor healthcare to individual patients, reducing the risk of adverse events and drug interactions while improving treatment effectiveness, safety, and compliance. Compounding pharmacists can customize medications based on a patient’s genetic makeup, medical history, allergies, preferences, and other relevant information. An example is Bioidentical Hormone Replacement Therapy (BHRT), especially for menopausal women, and transdermal creams for patients who cannot take oral opioids. According to the Personalized Medicine Coalition (PMC), 20% of the new molecular entities approved by the FDA in 2016 were personalized medications. The increasing use of personalized medicine is expected to boost the compounded pharmacy market’s growth.

Developing new drugs is expensive, risky, and time-consuming, with the average cost and time needed for a single new medication being 10-15 years and USD 2.6 billion, respectively, according to PhRMA. Only 12% of new molecular entities that enter clinical trials get FDA approval. This means many potentially effective and safe drugs do not reach the market due to clinical trial failures. Compounded pharmacies offer a solution by producing these medications in small quantities in collaboration with doctors. This is beneficial for patients seeking alternative therapies or those without access to conventional treatment options.

Buy Now Premium Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=22115

Segment Analysis

The global compounded pharmacy market is segmented by product, therapeutic area, and compounding type.

Product

The market is divided into Topical Medications, Parenteral Medications, Oral Medications, and Other Medications. The oral medications segment held the largest market share in 2023, driven by the benefits of oral dosage forms such as ease of use, painlessness, and self-administration. The availability of various oral pharmaceuticals, including tablets, powders, capsules, and liquid preparations like syrups and suspensions, further supports segment growth.

Therapeutic Area

The market is categorized into Hormone Replacement, Pain Management, Dermal Disorders, and Others. Pain management was the largest segment in 2023 due to the increasing incidence of chronic pain and the side effects of commercially available pain medications. Compounded pain management treatments offer advantages such as combining multiple drugs in one dose and avoiding the gastrointestinal system for patients with GI side effects.

Compounding Type

The market is segmented into Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing, Pharmaceutical Dosage Alteration, and Others. The pharmaceutical ingredient alteration segment held the largest market share in 2023, driven by the demand for customized medications that address individual patient needs by modifying pharmacological ingredients, including altering the ratio or concentration of a drug’s active components.

Regional Analysis

North America

The North American market, including the US and Canada, maintained the largest market share. This growth is driven by the unavailability of certain pharmaceuticals and the presence of numerous compounded pharmacies. According to the American Pharmacists Association, over 56,000 community pharmacies existed in the US as of October 2021, with 7,500 providing advanced compounding services.

Europe

The European market, comprising Germany, France, the UK, Italy, Spain, and the rest of Europe, has been growing steadily. Factors contributing to this growth include an aging population and advancements in medical care. Regulatory frameworks and guidelines from entities like the European Directorate for the Quality of Medicines (EDQM) ensure the safety, quality, and consistency of compounded pharmacy products.

Asia-Pacific

The Asia-Pacific market, including China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific, is expected to experience the fastest growth. This growth is driven by the increasing demand for customized medications, the rising incidence of chronic illnesses, improvements in healthcare infrastructure, and growing awareness and acceptance of complementary therapies.

Rest of the World

This region includes the Middle East, Africa, and Latin America. Growth in these markets is supported by the presence of numerous market competitors, an increasing number of healthcare institutions, higher healthcare spending power, and rising awareness of compounded pharmaceuticals. In Latin America, the market is anticipated to grow steadily due to the increasing number of compounding pharmacies and greater awareness of the benefits of compounded medications.

Browse In-depth Market Research Report (128 Pages) on Compounded Pharmacy: https://www.marketresearchfuture.com/reports/compounded-pharmacy-market-22115

Competitive Dynamics

MRFR recognizes the following companies as the key players in the global compounded pharmacy market – Fagron, Walgreen Co., JL Diekman and AQ Touchard (Fresh Therapeutics Compounding Pharmacy), Albertsons Companies, Galenic Laboratories Limited (Roseway Labs), The London Specialist Pharmacy Ltd (Specialist Pharmacy), Apollo Clinical Pharmacy, MEDS Pharmacy, Aurora Compounding, Formul8, and Fusion Apothecary.

Discover More Research Reports on Healthcare Industry by Market Research Future:

Lab-synthesized Heparin Market Research Report Information By Product (Low Molecular Weight Heparin and Unfractionated Heparin), By Source (Porcine and Bovine), By Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease, and Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

Soft Mist Inhalers Market Research Report Information By Product Type (Disposable and Reusable), By Age Group (Adult and Pediatric), By Application (Asthma and COPD), By Distribution Channel (Hospital pharmacies, Retail pharmacies and Online pharmacies), By End-use (Hospitals and clinics, Homecare settings and Other end users) and By Region (North America, Europe, Asia-Pacific and Rest Of The World) –Market Forecast Till 2032.

Lipid Regulators Market Research Report Information By Type (Statins and Non-statins), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) –Market Forecast Till 2032.

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Research Report Information by Diagnosis & Treatment {(Diagnosis [Microbiological Culture Test, Polymerase Chain Reaction, and Imaging Studies {Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography}, Treatment(Antibiotics, Antimicrobial Therapy, and Surgery)}, by End User (Hospitals, Ambulatory Surgery Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Forecast till 2032.

Endoscopic Vessel Harvesting Systems Market Research Report Information By Product (EVH Systems, Endoscopes, and Accessories), By Usability (Reusable and Disposable), By Application (Coronary Artery Disease (CAD), and Peripheral Artery Disease (PAD)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

Contact:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Tags: Compounded Pharmacy Market, Compounded Pharmacy Market Demand, Compounded Pharmacy Market Growth, Compounded Pharmacy Market Insights, Compounded Pharmacy Market Report, Compounded Pharmacy Market Research, Compounded Pharmacy Market Share, Compounded Pharmacy Market Size, Compounded Pharmacy Market Trends See Campaign: https://www.marketresearchfuture.com/reports/compounded-pharmacy-market-22115

Contact Information:

99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com

Tags:
Research Newswire, English